Michigan Cancer Registry Update: Cancer Data and Highlights MCC Board of Directors Meeting June 19, 2013

Topics to be Covered Cancer registry status Update on cancer incidence in Michigan New publication on cancer burden in Michigan Highlights of a new Web query tool

Twenty-Seven Years of Surveillance Data Covers the State of Michigan Population-based 1.3 million patients 1.5 million tumors Geocoded pop-based data Complete for Facilitated 115 research protocols

Collection Methods Passive Reporting o Quality Assurance Reviews Electronic or Paper Reports o Accept NAACCR formatted files Reports Initiated by Facilities Physicians contacted as needed

Information Collected Basic Identifiers Patient Demographics Site, Histology, Stage Method of Diagnosis Treatment Information Supplemental Information o Mortality Data – Cause and Occupation o Geocoding

Registry Uses Basic Statistics o Incidence/Mortality/Survival Cluster Investigations Cohort Studies Case Finding and Recruiting

Sampling of Current Research Suzanna Zick, UofM (National Cancer Institute) o Acupressure for Persistent Cancer Related Fatigue Maria Katapodi, UofM (CDC) o Cancer Screening in Breast Cancer Survivors and their Female Relatives R.T.I. International (Eli Lilly) o Forteo Post-Approval Surveillance Study: Case Series- Osteosarcoma o Forteo Patient Registry Perri Ruckart (DOD) o The Morbidity Study of Former Marines - USMC Base Camp Lejeune Kelly Yu – Westat (NCI) o Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening HPV Associated Work (CDC) o Surveillance o Prevalence o Measuring Vaccine Impact

Recent Trends in the Frequency of Cancer Incidence and Mortality 53,000 invasive cancer cases each year o Number fairly stable over five years through ,000 deaths due to cancer annually o Number stable to slightly rising Remains second leading cause of death o Leading cause of death for persons under 75 Leading cancers are prostate, lung, breast and colon o Lung, breast, pancreatic, and colon lead for Leading mortality sites are lung, breast, colon and pancreatic

Important Trends Lung cancer incidence and mortality rates have dropped o Mortality rates have declined by 15% from the peak in 1992 and 30 % in males o Incidence rates have declined by 19% from the peak in 1991 and 32% in males o Stage distributions are essentially unchanged o Survival at 5 years is improving Breast cancer incidence and mortality rates have dropped o Incidence has declined almost 20% and mortality by more than a third o Stage at diagnosis continues to improve while survival by stage creeps up o Disparities by race are still evident Colon Cancer incidence and mortality are dropping o Incidence has declined 30% and mortality rates have declined 40% since 1985 o Stage at diagnosis shows some improvement, shifting to early stage o Survival by stage at diagnosis is not changing

New Ways to Access Data Web Site is the portal o Statistics and Reports o Select Statistics and Reports Cancer Statistics o Select Cancer Statistics